No Photo Available

Last Update

2016-09-14T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Alan Moy?

Dr. Alan B. Moy

Direct Phone: (319) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Cellular Engineering Technologies Inc.

2500 Crosspark Rd

Coralville, Iowa 52241

United States

Company Description

CET specializes in stem cell research, tissue engineering and cancer biology. We develop media, provide and conduct research on stem cells obtained from human non-embryonic sources, such as adipose tissue, bone marrow, Wharton's jelly, umbilical cord bloo ... more

Find other employees at this company (7)

Background Information

Employment History

Scientific Director

John Paul II Stem Cell Research Institute

Adjunct Professor of College of Engineering

University of Iowa

Pulmonologist

Mercy Hospital

Affiliations

Member Login
IAHCP

Founder
CET , Inc

Founder
JP2MRI

Education

M.D.

Creighton

M.D.

Creighton University

bachelor's degree

biochemistry

University of California , Davis

degree

biochemistry

University of California at Davis

Web References (61 Total References)


Pulmonary Associates of Iowa City ...

www.paiowacity.com [cached]

Pulmonary Associates of Iowa City Inc. was founded by Dr. Alan Moy. Dr. Moy is the Founder of Cellular Engineering Technologies, a biotechnology company in Coralville, Iowa that focuses on commercial preclinical applications in tissue engineering, which includes non-human embryonic stem cell research for preclinical drug development. Dr. Moy is also the Director of the John Paul II Stem Cell Research Institute, whose mission focuses on educational and translational adult stem cell research.


According to Dr Alan Moy, ...

gregandjennifer.com [cached]

According to Dr Alan Moy, CEO of Cellular Engineering Technologies (CET), and Director of the recently formed John Paul II Stem Cell Research Institute (JP2SRI), he pointed out the following facts in a 2007 interview with Mercatornet:

...
Alan Moy MD


CET - About CET

celleng-tech.com [cached]

Alan Moy, MD Chief Executive Officer and Founder

Alan Moy, M.D., a physician-scientist, was previously on faculty for 13 years at the University of Iowa Department of Internal Medicine and Biomedical Engineering. Dr. Moy founded the company in 2000. Dr. Moy received a Bachelor's degree in Biochemistry from the University of California, Davis and an M.D. from Creighton University. He received postgraduate education in Internal Medicine from St. Louis University and completed a fellowship in Pulmonary Medicine and Critical Care Medicine at the University of Iowa. Dr. Moy's research expertise is in the area of vascular biology and tissue engineering. Dr. Moy is also listed in the 2010 Who's Who in America and is listed in 2011 as a Leading Physician of the World by the International Association of Healthcare Professions.


Cellular Engineering ...

www.catholicglobe.org [cached]

Cellular Engineering Technologies was founded by Dr. Alan Moy, a physician-scientist with expertise in stem cell technology and cancer biology. Dr. Alan Moy, also the founder of JP2MRI, is a pulmonologist who practices through Pulmonary Associates at Mercy Hospital in Iowa City.

"Cancer patients are subjected to some of the greatest challenges in healthcare," Dr. Moy explained.


Cellular Engineering ...

celleng-tech.com [cached]

Cellular Engineering Technologies was founded by Dr. Alan Moy, a physician-scientist with expertise in stem cell technology and cancer biology. CET is a leader in adult stem cell technology whose mission is to decrease the cost and increase the efficiency of drug development. Using its expertise, CET has now developed the next generation of cancer technology to advance the field. CET is partnering with JP2MRI to create a new paradigm in cancer diagnosis, treatment and drug development. "Cancer patients are subjected to some of the greatest challenges in healthcare," says Dr. Moy. Chemotherapy has only modestly improved the 5-year survival rate by 2 percent for adult solid cancers. The healthcare system spends over $110,000 a year to treat a cancer patient with chemotherapy, four times the amount for cancer patients not receiving chemotherapy. It takes 12-15 years and over 1 billion dollars to bring a new cancer drug to market and there is a 95 percent failure rate associated with the process. Chemotherapy has serious side effects and is frequently administered without any rigorous testing to specifically identify which cancer drugs will be effective or not. "Genetic testing has been widely pursued to improve diagnostic testing and treatment but there are major deficiencies in such technology," says Dr. Moy.

Similar Profiles

Other People with this Name

Other people with the name Moy

Russ Moy
Grant Thornton LLP

Tanya Moy
South32 Limited

Alex Moy
Haskell Brokerage Corp

Kevin Moy
Bergelectric Corporation

Cody Moy
Henkel KGaA

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory